(MENAFN- Robotics & automation News) MilliporeSigma partners with Opentrons Labworks to create 'Lab of the Future'
January 28, 2025 by Mark Allinson
MilliporeSigma , the US and Canada Life Science business of Merck, of Germany, and Opentrons Labworks , a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom Opentrons Flex workstation.
Scientists and engineers will collaborate to develop and verify platform workflows utilizing the broad offering of automation-enabled assays from the Life Science business of Merck, Darmstadt, Germany.
Together, the custom workstation and automation-enabled assays will deliver increased consistency and higher throughput by reducing manual processing and repetitive tasks with a user-friendly robotic system.
Jean-Charles Wirth, head of science and lab solutions for the life science business of Merck, Darmstadt, Germany, says:“Our customers are prioritizing tools and technologies that improve reproducibility and productivity, allowing them to focus on more complex tasks that take their science further, faster.
“Our partnership with Opentrons reinforces our focus to automate and digitalize the lab – supporting scientists at all stages with tools that can increase efficiency, safety, and success rates of delivering new potential therapeutics.”
Customers can place orders for workstations and assay kits starting mid-2025. Applications will include broad workflows across protein sample preparation, molecular, cell, and other biochemical and chemistry workflows launching throughout the length of the agreement.
Jonathan Brennan-Badal, CEO of Opentrons, says:“Part of our commitment to making lab automation as accessible as possible is finding partners who share a similar vision.
“The Life Science business of Merck, Darmstadt, Germany is a proven leader in terms of the breadth and quality of products they offer for pharmaceutical development and manufacturing, and we're excited to combine that with our ability to provide world-class automation, service and support.”
By combining the automation expertise and service excellence of Opentrons with the powerful R&D, supply chain, and quality systems of the Life Science business of Merck, Darmstadt, Germany the company says it will bring reliable products streamlining research from sample prep to analysis for immunodetection, protein research, enzyme technology, genome editing, omics research, pharmaceutical development, service and testing and cell culture.
This adds to existing Biology innovations to increase lab productivity from the Life Science business of Merck, Darmstadt, Germany , like the Millicell DCI Digital Cell Imager that allows for accelerated cell culture analysis with an intuitive interface while also adding to the company's“commitment to provide next-generation biology solutions such as their recent acquisition of HUB Organoids Holding”.
MENAFN28012025005532012229ID1109139929
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.